Stephen Fadem

Introduction Chronic kidney disease (CKD) is a common health issue affecting 7–12% of adults worldwide (1). It causes a large disease burden and ranks fourteenth on the list of leading causes of death in the world (2). Renal disease is a common comorbidity in adults with atopic dermatitis (3). In a case–control study with approximately 100,000 participants, individuals with atopic dermatitis were found to have a higher risk of CKD compared to those without atopic dermatitis (4).

Obesity and chronic kidney disease (CKD) are becoming increasingly common and have reached epidemic levels (1, 2). Furthermore, obesity is a risk factor for CKD and may hasten its progression (3). In patients with end-stage renal disease (ESRD), obesity may prevent or delay access to a kidney transplant as well as affect peri- and post-transplantation outcomes (4, 5).

employment chronic hemodialysis kidney transplantation The invention of hemodialysis in 1943 was, at its implementation, immediately recognized as a bridge for patients with kidney failure (1). In 1947, dialysis was brought to America and immediately envisioned by John Merrill, a pioneer in dialysis, as a stopgap measure for patients awaiting a kidney transplant (2).